Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
roxithromycin, Quantity: 300 mg
Arrotex Pharmaceuticals Pty Ltd
Roxithromycin
Tablet, film coated
Excipient Ingredients: sodium starch glycollate type B; colloidal anhydrous silica; titanium dioxide; propylene glycol; poloxamer; hypromellose; hyprolose; glucose; maize starch; sodium starch glycollate type A; purified talc; magnesium stearate; povidone
Oral
5 tablets
(S4) Prescription Only Medicine
Adults: The treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms:- * Upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. * Lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. * Skin and skin structure infections. * Nongonococcal urethritis.
Visual Identification: White to off-white, round, convex film coated tablets.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2008-04-10